Literature DB >> 1008618

Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus.

E J Goetzl.   

Abstract

Polymorphonuclear (PMN) leucocytes from 4 patients with untreated systemic lupus erythematosus (SLE) showed defective random migration (P less than 0-05) and depressed chemotactic responses to C5a and kallikrein (P less than 0-01) compared to PMN leucocytes from normal subjects, or patients with rheumatoid arthritis (4) or Felty's syndrome (4) when examined at a standardized cell concentration with a micropore filter radioassay but not with a conventional Boyden technique. Normal in vitro enhancement of PMN leucocyte random and chemotactic migration by sodium ascorbate was absent in SLE and Felty's syndrome, but sodium ascorbate gave normal stimulation of hexose monophosphate shunt activity in the PMN leucocytes precluding a defect in ascorbate transport.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008618      PMCID: PMC1006594          DOI: 10.1136/ard.35.6.510

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Plasma and cell-derived inhibitors of human neutrophil chemotaxis.

Authors:  E J Goetzl
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

2.  Disseminated lupus erythematosus; analysis of thirty-four cases.

Authors:  M A SHEARN; B PIROFSKY
Journal:  AMA Arch Intern Med       Date:  1952-12

Review 3.  Hematologic abnormalities in rheumatoid arthritis.

Authors:  A G Mowat
Journal:  Semin Arthritis Rheum       Date:  1972       Impact factor: 5.532

Review 4.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

5.  Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus.

Authors:  L Brandt; H Hedberg
Journal:  Scand J Haematol       Date:  1969

6.  Felty's syndrome.

Authors:  J S Louie; C M Pearson
Journal:  Semin Hematol       Date:  1971-07       Impact factor: 3.851

7.  Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis.

Authors:  R B Trimble; A S Townes; H Robinson; S B Kaplan; R W Chandler; A S Hanissian; A T Masi
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

8.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  5 in total

1.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect.

Authors:  E C Moore; F Cohen; S D Douglas; V Gutta
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.

Authors:  J R Walker; D W James; M J Smith
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

3.  Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.

Authors:  D H Goddard; A P Kirk; J R Kirwan; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

5.  Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor.

Authors:  S M Hanlon; G S Panayi; R Laurent
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.